2006•Practical Preventive MedicineRequires access

Plasma Coagulation Factors in Patients With Cirrhosis

Xie Rihua

Open publisher page 0 citations

Abstract

Objective The plasma coagulation factors were evaluated in 60 patients with liver cirrhosis. Methods The blood prothrombin time(PT),activated partial thromboplastin time(APTT) and plasma fibrinogen level(FIB) were determined by coagulant turbidity method.Blood platelet count(PLT) was measured with ABBOTT CELL-DYN1600 automatic blood cell counter.The activities of coagulation factors were detected by one clotting stage method. Results The PT and APTT in patients with cirrhosis were significantly prolonged than that of normal controls as well as the decrement of FIB level and PLT count(P0.05).The activity of factor Ⅷ was elevated.In contrast,the activities of other coagulation factors,such as FⅡ,FⅤ,FⅦ,FⅨ,FⅪ,FⅫ were decreased﹙(P0.05). Conclusion The PT and APTT interval,the levels of FIB and PLT count and all other coagulation factors are abnormal in patients with hepatic cirrhosis,they are valuable in identifying coagulation disorders,characterizing the degree of liver damage,predicting bleeding tendency and estimating prognosis.

About this research paper

What this paper is about

Objective The plasma coagulation factors were evaluated in 60 patients with liver cirrhosis. Methods The blood prothrombin time(PT),activated partial thromboplastin time(APTT) and plasma fibrinogen level(FIB) were determined by coagulant turbidity method.Blood platelet count(PLT) was measured with ABBOTT CELL-DYN1600 automatic blood cell counter.The activities of coagulation factors were detected by one clotting stage method. Results The PT and APTT in patients with cirrhosis were significantly prolonged than that of normal controls as well as the decrement of FIB level and PLT count(P0.05).The activity of factor Ⅷ was elevated.In contrast,the activities of other coagulation factors,such as FⅡ,FⅤ,FⅦ,FⅨ,FⅪ,FⅫ were decreased﹙(P0.05). Conclusion The PT and APTT interval,the levels of FIB and PLT count and all other coagulation factors are abnormal in patients with hepatic cirrhosis,they are valuable in identifying coagulation disorders,characterizing the degree of liver damage,predicting bleeding tendency and estimating prognosis.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective The plasma coagulation factors were evaluated in 60 patients with liver cirrhosis. Methods The blood prothrombin time(PT),activated partial thromboplastin time(APTT) and plasma fibrinogen level(FIB) were determined by coagulant turbidity method.Blood platelet count(PLT) was measured with ABBOTT CELL-DYN1600 automatic blood cell counter.The activities of coagulation factors were detected by one clotting stage method. Results The PT and APTT in patients with cirrhosis were significantly prolonged than that of normal controls as well as the decrement of FIB level and PLT count(P0.05).The activity of factor Ⅷ was elevated.In contrast,the activities of other coagulation factors,such as FⅡ,FⅤ,FⅦ,FⅨ,FⅪ,FⅫ were decreased﹙(P0.05). Conclusion The PT and APTT interval,the levels of FIB and PLT count and all other coagulation factors are abnormal in patients with hepatic cirrhosis,they are valuable in identifying coagulation disorders,characterizing the degree of liver damage,predicting bleeding tendency and estimating prognosis.

Key concepts: Partial thromboplastin time, Cirrhosis, Prothrombin time, Fibrinogen, Coagulation, Medicine, Internal medicine, Gastroenterology

Related papers

Back to paper searchBrowse research topicsOriginal source
Plasma Coagulation Factors in Patients With Cirrhosis — Research Paper | ScholarLens